Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 892-898

  Lamacchia, Olga ^a   Nicastro, Vincenzo ^a   Camarchio, Donatella ^a   Valente, Umberto ^a   Grisorio, Rosaria ^a   Gesualdo, Loreto ^a   Cignarelli, Mauro ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

diabetes mellitus; kidney dysfunction; perirenal fat; uricaemia; visceral obesity

Indexed keywords

FAT;

ABDOMINAL WALL MUSCULATURE; ADIPOSE TISSUE; ADULT; AGED; ALBUMINURIA; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIAGNOSTIC VALUE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PARANEPHRIC FAT; PERINEPHRIC FAT; PRIORITY JOURNAL; THICKNESS; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

ALBUMINURIA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERURICEMIA; INTRA-ABDOMINAL FAT; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 79952151945     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq522     Document Type: Article

References (48)

1. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007;2:550-562
2. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008;73:19-33 (Pubitemid 350273639)
3. Hall JE, Crook ED, Jones DW et al. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 2002;324:127-137
4. de Boer IH, Katz R, Fried LF et al. Obesity and change in estimated GFR among older adults. Am J Kidney Dis 2009;54:1043-1051
5. Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens 2010;19:227-234
6. Gonçalves Torres MR, Cardoso LG, de Abreu VG et al. Temporal relation between body mass index and renal function in individuals with hypertension and excess body weight. Nutrition 2009;25:914-919
7. Kawamoto R, Kohara K, Tabara Y et al. An association between body mass index and estimated glomerular filtration rate. Hypertens Res 2008;31:1559-1564
8. Noori N, Hosseinpanah F, Nasiri AA et al. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 2009;19:228-327
9. Gelber RP, Gaziano JM, Orav EJ et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008;52:605-615
10. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004;140:167-174
11. Sanches FM, Avesani CM, Kamimura MA et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008;52:66-73 (Pubitemid 351853257)
12. Kawasaki S, Aoki K, Hasegawa O et al. Sonographic evaluation of visceral fat by measuring para-and perirenal fat. J Clin Ultrasound 2008;36:129-133 (Pubitemid 351441221)
13. Rea DJ, Heimbach JK, Grande JP et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006;70:1636-1641 (Pubitemid 44607000)
14. Goumenos DS, Kawar B, El Nahas M et al. Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant 2009;24:3732-3738
15. Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis 2007;17:757-762 (Pubitemid 350088441)
16. Lamacchia O, Pinnelli S, Camarchio D et al. Waist-to-height ratio is the best anthropometric index in association with adverse cardiorenal outcomes in type 2 diabetes mellitus patients. Am J Nephrol 2009;29:615-619
17. Ritz E, Koleganova N. Obesity and chronic kidney disease. Semin Nephrol 2009;29:504-511
18. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
19. Levey AS, Stevens LA, Schmid CH et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
20. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 2002;39: S46-S75
21. Gatling W, Knight C, Mullee MA et al. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1998;5:343-347
22. Lamacchia O, Nicastro V, Camarchio D et al. Waist circumference is strongly associated with renal resistive index in normoalbuminuric patients with type 2 diabetes. Am J Nephrol 2008;28:54-58 (Pubitemid 350126493)
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and the Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
24. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003;14:281-287 (Pubitemid 36688207)
25. Montani JP, Carroll JF, Dwyer TM et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 2004;28: S58-S65 (Pubitemid 40143850)
26. Lapidus L, Bengtsson C, Larsson B et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 198; 289:1257-1261
27. Fujioka S, Matsuzawa Y, Tokunaga K et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and metabolism in human obesity. Metabolism 1987;36:54-59 (Pubitemid 17016386)
28. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001;15:312-321 (Pubitemid 32141423)
29. Harman PK, Kron IL, McLachlan HD et al. Elevated intra-abdominal pressure and renal function. Ann Surg 1982;196:594-597 (Pubitemid 12003660)
30. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997;10:49S-55S (Pubitemid 27239831)
31. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008;51:714-725
32. Ishimura E, Nishizawa Y, Kawagishi T et al. Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int 1997;51:1920-1927 (Pubitemid 27252763)
33. Boddi M, Cecioni I, Poggesi L et al. Renal resistive index early detects chronic tubulointerstitial nephropathy in normo and hypertensive patients. Am J Nephrol 2006;26:16-21
34. Leite CC, Wajchenberg BL, Radominski R et al. Intra-abdominal thickness by ultrasonography to predict risk factors for cardiovascular disease and its correlation with anthropometric measurements. Metabolism 2002;51:1034-1040
35. Armellini F, Zamboni M, Castelli S et al. Measured and predicted total and visceral adipose tissue in women. Correlations with metabolic parameters. Int J Obes Relat Metab Disord 1994;18:641-647 (Pubitemid 24268671)
36. Armellini F, Zamboni M, Rigo L et al. The contribution of sonog-raphy to the measurement of intra-abdominal fat. J Clin Ultrasound 1990;18:563-567 (Pubitemid 20250729)
37. Suzuki R, Watanabe S, Hirai Y et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous. Am J Med 1993;95:309-314 (Pubitemid 23270289)
38. Retnakaran R, Cull CA, Thorne KI et al. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes 2006;55:1832-1839 (Pubitemid 44324140)
39. Mazzucco G, Bertani T, Fortunato M et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002;39:713-720 (Pubitemid 34263344)
40. Cignarelli M, Lamacchia O, Cardinale G et al. Metabolic syndrome and albuminuria showanadditive effect in modulating glomerularfiltration rate in patients with type 2 diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2009;3:139-142
41. So WY, Wang Y, Ng MC et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diab Care 2006;9:2046-2052
42. Nag S, Bilous R, Kelly W et al. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study. Diabet Med 2007;24:10-17 (Pubitemid 46103066)
43. Pekiner C, McLean WG. Neurofilament protein phosphorylation in spinal cord of experimental diabetic rats. J Neurochem 1991;56:1362-1367 (Pubitemid 21902058)
44. Terada M, Yasuda H, Kikkawa R. Delayed Wallerian degeneration and increased neurofilament phophosrylation in sciatic nerves of rats with streptozotocin-induced diabetes. J Neuro Sci 1998;155:23-30 (Pubitemid 28141054)
45. Diemel LT, Stevens EJ, Willars GB et al. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldolase reductase inhibition. Neurosci Lett 1992;137:253-256
46. Diemel LT, Brewster WJ, Fernyhough P et al. Expression of neuro-peptides in experimental diabetes; effect of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res 1994;21:171-175 (Pubitemid 24034923)
47. Willars GB, Calcutt NA, Compton AM et al. Substance P levels in peripheral nerve, skin atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effect of aldolase reductase inhibition. J Neurol Sci 1989;91:153-164 (Pubitemid 19161701)
48. Fernyhough P, Gallagher A, Averill SA et al. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999;48:881-889 (Pubitemid 29153090)